Aptevo Therapeutics Inc (APVO)

5.90 -4.11 (-41.06%) USD  |  NASDAQ  |  Dec 12, 13:31
More

Aptevo Therapeutics Max Drawdown (5Y): 99.99% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for APVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Johnson & Johnson 27.36%
Merck & Co Inc 27.26%
Eyenovia Inc 98.80%
Applied Therapeutics Inc 99.03%
NovaBay Pharmaceuticals Inc 99.98%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -146.00
Beta (5Y) 5.014
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 243.8%
Historical Sharpe Ratio (5Y) -0.3242
Historical Sortino (5Y) -1.280
Monthly Value at Risk (VaR) 5% (5Y Lookback) 56.43%